Skip to main content
Top
Published in: Critical Care 3/2002

01-06-2002 | Meeting report

What are the challenges of translating positive trial results in severe sepsis into clinical practice? A media roundtable debate, 18 March 2002, Brussels, Belgium

Author: Jonathan Ball

Published in: Critical Care | Issue 3/2002

Login to get access

Abstract

The clinical syndrome of sepsis is common, increasing in incidence and responsible for as many deaths annually as ischaemic heart disease. Two recent interventional trials have demonstrated that early recognition and intervention can result in dramatic reductions in acute (28-day) mortality. This roundtable discussion was convened to identify ways in which these recent advances could be translated into clinical practice. The first obstacle surrounds the woolly and confusing terminology surrounding 'sepsis' with the systemic inflammatory response syndrome (SIRS) model largely discredited. Overcoming this should facilitate wider recognition, not only among health care providers (in particular those working in acute specialties outside intensive care units [ICUs]) but also politicians and the general public. Such education is vital if early recognition and intervention are to be successfully implemented.
Literature
1.
go back to reference Abraham E, Matthay MA, Dinarello CA, Vincent JL, Cohen J, Opal SM, Glauser M, Parsons P, Fisher CJ Jr, Repine JE: Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med 2000, 28: 232-235. 10.1097/00003246-200001000-00039CrossRefPubMed Abraham E, Matthay MA, Dinarello CA, Vincent JL, Cohen J, Opal SM, Glauser M, Parsons P, Fisher CJ Jr, Repine JE: Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med 2000, 28: 232-235. 10.1097/00003246-200001000-00039CrossRefPubMed
2.
go back to reference Farinas-Alvarez C, Farinas MC, Fernandez-Mazarrasa C, Llorca J, Delgado-Rodriguez M: Epidemiological differences between sepsis syndrome with bacteremia and culture-negative sepsis. Infect Control Hosp Epidemiol 2000, 21: 639-644.CrossRefPubMed Farinas-Alvarez C, Farinas MC, Fernandez-Mazarrasa C, Llorca J, Delgado-Rodriguez M: Epidemiological differences between sepsis syndrome with bacteremia and culture-negative sepsis. Infect Control Hosp Epidemiol 2000, 21: 639-644.CrossRefPubMed
3.
go back to reference Vincent JL, Mercan D: Dear Sirs, what is your PCT? Intensive Care Med 2000, 26: 1170-1171. 10.1007/s001340000605CrossRefPubMed Vincent JL, Mercan D: Dear Sirs, what is your PCT? Intensive Care Med 2000, 26: 1170-1171. 10.1007/s001340000605CrossRefPubMed
4.
5.
go back to reference Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002CrossRefPubMed Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002CrossRefPubMed
6.
go back to reference Graf J, Doig GS, Cook DJ, Vincent JL, Sibbald WJ: Randomized, controlled clinical trials in sepsis: has methodological quality improved over time? Crit Care Med 2002, 30: 461-472. 10.1097/00003246-200202000-00032CrossRefPubMed Graf J, Doig GS, Cook DJ, Vincent JL, Sibbald WJ: Randomized, controlled clinical trials in sepsis: has methodological quality improved over time? Crit Care Med 2002, 30: 461-472. 10.1097/00003246-200202000-00032CrossRefPubMed
8.
go back to reference American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20: 864-874.CrossRef American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20: 864-874.CrossRef
9.
go back to reference Vincent JL: Dear SIRS, I'm sorry to say that I don't like you. Crit Care Med 1997, 25: 372-374. 10.1097/00003246-199702000-00029CrossRefPubMed Vincent JL: Dear SIRS, I'm sorry to say that I don't like you. Crit Care Med 1997, 25: 372-374. 10.1097/00003246-199702000-00029CrossRefPubMed
10.
go back to reference Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344: 699-709. 10.1056/NEJM200103083441001CrossRefPubMed Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344: 699-709. 10.1056/NEJM200103083441001CrossRefPubMed
11.
go back to reference Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, the Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345: 1368-1377. 10.1056/NEJMoa010307CrossRefPubMed Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, the Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345: 1368-1377. 10.1056/NEJMoa010307CrossRefPubMed
12.
go back to reference Vincent JL: Reflection and reaction: sepsis definitions. Lancet Infect Dis 2002, 2: 135. 10.1016/S1473-3099(02)00232-3CrossRefPubMed Vincent JL: Reflection and reaction: sepsis definitions. Lancet Infect Dis 2002, 2: 135. 10.1016/S1473-3099(02)00232-3CrossRefPubMed
13.
go back to reference Cook R, Cook D, Tilley J, Lee K, Marshall J: Multiple organ dysfunction: baseline and serial component scores. Crit Care Med 2001, 29: 2046-2050. 10.1097/00003246-200111000-00002CrossRefPubMed Cook R, Cook D, Tilley J, Lee K, Marshall J: Multiple organ dysfunction: baseline and serial component scores. Crit Care Med 2001, 29: 2046-2050. 10.1097/00003246-200111000-00002CrossRefPubMed
14.
go back to reference Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruin-ing H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis – Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22: 707-710. 10.1007/s001340050156CrossRefPubMed Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruin-ing H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis – Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22: 707-710. 10.1007/s001340050156CrossRefPubMed
17.
go back to reference Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345: 1359-1367. 10.1056/NEJMoa011300CrossRefPubMed Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345: 1359-1367. 10.1056/NEJMoa011300CrossRefPubMed
18.
go back to reference Opal SM: Clinical impact of novel anticoagulation strategies in sepsis. Curr Opin Crit Care 2001, 7: 347-353. 10.1097/00075198-200110000-00006CrossRefPubMed Opal SM: Clinical impact of novel anticoagulation strategies in sepsis. Curr Opin Crit Care 2001, 7: 347-353. 10.1097/00075198-200110000-00006CrossRefPubMed
19.
go back to reference Cost-effectiveness of drotrecogin alfa (activated) (Xigris™) in severe sepsis. Crit Care Med 2002, 30: 492-493. 10.1097/00003246-200202000-00045 Cost-effectiveness of drotrecogin alfa (activated) (Xigris™) in severe sepsis. Crit Care Med 2002, 30: 492-493. 10.1097/00003246-200202000-00045
Metadata
Title
What are the challenges of translating positive trial results in severe sepsis into clinical practice? A media roundtable debate, 18 March 2002, Brussels, Belgium
Author
Jonathan Ball
Publication date
01-06-2002
Publisher
BioMed Central
Published in
Critical Care / Issue 3/2002
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc1503

Other articles of this Issue 3/2002

Critical Care 3/2002 Go to the issue